Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Our mission is to discover new ways to improve and extend people’s lives. Our vision is to be a trusted leader in changing the practice of medicine.
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Our mission is to discover new ways to improve and extend people’s lives. Our vision is to be a trusted leader in changing the practice of medicine.
User experience (UX) is booming: employment, salaries, and the profile of the profession are all on the rise. But are we losing sight of what really matters?
Drawing parallels between the current boom in UX, Dutch tulip mania and Ireland's recent property boom, Morgan argues that UX is showing bubble-like properties, and that it needs to refocus on value and delivering meaningful results to business to remain relevant.
From the UX Masterclass, Johannesburg, March 2012
Pfizer Tops, Novartis and Johnson & Johnson follows on Social media this Febr...Simplify360
Key Findings:
1) Pfizer is the most social pharmaceutical company in February.
2) Pfizer is the most mentioned brand on Social media followed by Novartis
3) Bayer and Johnson & Johnson combined constitutes 70% of the Industry’s Facebook fan base
4) With the Twitter engagement score of 94, Pfizer bagged the first rank among the top10.
5) With an SSI of 81, Novartisis the biggest gainer during February 2014, it moved from 5th rank in January to 2nd rank in February 2014.
6) Eli Lilly & Co tweeted the most on Twitter.
7) Bayer & Novo Nordisk has highly active fan base and at the same time a very high fan base.
A total of 20 global companies were considered in the analysis.
Business Case: Sales forecasting with SAS Advanced Analytics for the Pharmace...Claudio Menozzi
Goal: Predict New Product Market Penetration
Company: One of the world’s largest biotech companies, with more than 7,000 employees across six continents and a rapidly expanding product portfolio and a growing pipeline.
Business Area: The company provides medical product support across the Hospital Channel
Business Needs: Understanding the adoption of the existing products and predict adoption of new products allows to increase the customer service, adoption and eventually profitability
Project dealt by Achille Masserano, Enterprise Information Manager at Blue BI
Case of Daiichi Sankyo takeover of RanbaxyAdityakapoors
This case was prepared with the objective to study merger synergy, valuation and how poor due diligence will have consequences on companies Balance Sheet.
Learning
Base SAS,
Advanced SAS,
Proc SQl,
ODS,
SAS in financial industry,
Clinical trials,
SAS Macros,
SAS BI,
SAS on Unix,
SAS on Mainframe,
SAS interview Questions and Answers,
SAS Tips and Techniques,
SAS Resources,
SAS Certification questions...
visit http://sastechies.blogspot.com
In 1993, "la Caisse de dépôt et placement du Québec" invested 5M in Axcan Pharma (now Aptalis) for a 25% ownership. In 2008, a US private equity fund acquired all shares of Axcan for 1.3B, or 65 times its value 15 years earlier.
User experience (UX) is booming: employment, salaries, and the profile of the profession are all on the rise. But are we losing sight of what really matters?
Drawing parallels between the current boom in UX, Dutch tulip mania and Ireland's recent property boom, Morgan argues that UX is showing bubble-like properties, and that it needs to refocus on value and delivering meaningful results to business to remain relevant.
From the UX Masterclass, Johannesburg, March 2012
Pfizer Tops, Novartis and Johnson & Johnson follows on Social media this Febr...Simplify360
Key Findings:
1) Pfizer is the most social pharmaceutical company in February.
2) Pfizer is the most mentioned brand on Social media followed by Novartis
3) Bayer and Johnson & Johnson combined constitutes 70% of the Industry’s Facebook fan base
4) With the Twitter engagement score of 94, Pfizer bagged the first rank among the top10.
5) With an SSI of 81, Novartisis the biggest gainer during February 2014, it moved from 5th rank in January to 2nd rank in February 2014.
6) Eli Lilly & Co tweeted the most on Twitter.
7) Bayer & Novo Nordisk has highly active fan base and at the same time a very high fan base.
A total of 20 global companies were considered in the analysis.
Business Case: Sales forecasting with SAS Advanced Analytics for the Pharmace...Claudio Menozzi
Goal: Predict New Product Market Penetration
Company: One of the world’s largest biotech companies, with more than 7,000 employees across six continents and a rapidly expanding product portfolio and a growing pipeline.
Business Area: The company provides medical product support across the Hospital Channel
Business Needs: Understanding the adoption of the existing products and predict adoption of new products allows to increase the customer service, adoption and eventually profitability
Project dealt by Achille Masserano, Enterprise Information Manager at Blue BI
Case of Daiichi Sankyo takeover of RanbaxyAdityakapoors
This case was prepared with the objective to study merger synergy, valuation and how poor due diligence will have consequences on companies Balance Sheet.
Learning
Base SAS,
Advanced SAS,
Proc SQl,
ODS,
SAS in financial industry,
Clinical trials,
SAS Macros,
SAS BI,
SAS on Unix,
SAS on Mainframe,
SAS interview Questions and Answers,
SAS Tips and Techniques,
SAS Resources,
SAS Certification questions...
visit http://sastechies.blogspot.com
In 1993, "la Caisse de dépôt et placement du Québec" invested 5M in Axcan Pharma (now Aptalis) for a 25% ownership. In 2008, a US private equity fund acquired all shares of Axcan for 1.3B, or 65 times its value 15 years earlier.
Jason Arnold, Kari Froehlich, Mat McBride, Stanley Parker, Ann.docxchristiandean12115
Jason Arnold, Kari Froehlich, Mat McBride, Stanley Parker, Ann Utterback, Robin Chapman, Gail Christian
Arizona State Unive rsity
Introduction
Valeant Pharmaceut icals International, Inc. pro -
motes itself as a multinational specialty pharmaceuti-
cal company with a diverse product portfolio focusing
on branded pharmaceuticals , branded and unbranded
generics, and over-the- counter (OTC) products special-
izing in neurology and dermatology.1 Product sales focus
on North America, Central Europe, Mexico, Brazil, and
Australia, with manufacturing sites in Canada, Brazil,
Poland, and Mexico. 2
In his 2006 me ssa ge to shareholders, Timothy
C. Tyson, then president and CEO, reflected , "In
many ways, 2006 was a life-changing year for Valeant
Pharmaceuticals. It was a challenging year-one that
certainly stretched us and tested our resolve. "3 That
was the year that Valeant lost its chairman, Robert
W. O'Leary, to cancer. Valeant would face a new set
of challenges in the fall of 2010, when it merged with
Canada's Biovail Corporation. Although Valeant even -
tually recovered fro m the loss of chairman Robert
W. O'Leary, would it be able to overcome the challenges
of the merger and strategically position itself to capture a
significant portion of the global pharmaceutical market
that was expected to reach $1.1 trillion by 2014?4
Although we give a brief history of Valeant here,
this case focuses on the Biovail merger and Valeant's
neurology division . This division manufactures
and markets products to treat Parkinson's disease
(PD), epilepsy, migraines, depression , chronic pain,
Huntington's disease , and myasthenia gravis. A central
question is whether Valeant will be able to capitalize
on an aging population's growing demand for its new
epilepsy drug, retigabine, and its other products. Also ,
due to significant restructuring efforts occurring before
and resulting from the merger, an important question
is whether the changes will yield the benefits promised
to sha~eholders ·and enable the firm to compete more
effectively. The answers to these questions and others
will influence Valeant's future success.
History
Valeant Pharmaceuticals was founded in 1960 by
Milan Panic, a Yugoslav defector. The company started
in California and was originally called Intern ational
Chemical & Nuclear Corp. (ICN) . Panic ran the
company for 43 years. 5 Initially, the company's primary
business involved chemical and drug sales, but it grew
through acquisitions of small drug companies. In 1963,
the company launched its IP0 .6
In 1970, ICN scientists discovered ribavirin, and in
1985, it received US Food and Drug Administration (FDA)
approval for the drug to be used as a treatment for lung
infections in children. As a blockbuster drug, ribavirin
powered ICN's growth and reputation for decades .7 In
later years, Panic directed ICN to promote ribavirin as
a treatment for AIDS and hepatitis C.8 During the 70s,
ri.
Mechanisms for bringing together a broad range of stakeholders that share common interests in product
innovation to increase the number of impactful therapies for skin diseases such as alopecia areata.
Nutrify Today has been working to add value to the responsible nutrition industry to the best of its capacity. In our pursuit of enabling and empowering responsible nutrition businesses; we are happy to bring to you a monthly bulletin on interesting business subjects in responsible nutrition. It will focus on new innovations, new patents, interesting business ideas, and opinions from industry stakeholders globally. We expect this bulletin to be a lead generator, business opportunities generator and potentially triggering of ideas that could lead to great responsible nutrition products. Feel free to contribute, suggest, advise at hello@nutrifytoday.com
BioSyent (RX.V or BIOYF) is a rapidly growing pharmaceutical company that acquires or in-licenses proven drugs and markets them in Canada. Their business model is to build and sell a portfolio of products that have a peak penetration potential that is too small for major pharmaceutical companies. What has fascinated us about BioSyent is their ability to consistently grow revenue and earnings. In fact, their pharmaceutical sales have grown sequentially for the past 12 quarters, which is very rare in the microcap space. In 2012 they announced several new products that they have added to their portfolio plus they have a nice pipeline of additional products that we expect to further fuel their growth. In the most recent quarter they grew revenues 60% and net income 79% year/year. Listen to CEO Rene Goehrum as he tells the story.
How to best enjoy South of France beautiful Provence with a tour into Vaucluse area : Avignon, Orange, Apt, Luberon...
11 Best Things to Do in Vaucluse, France
En tant qu'entrepreneurs, sommes-nous des vendeurs malgré nous ? Pourquoi est-il important de bien vendre son idée, même si nous ne sommes pas vendeurs de métier.
Memorandum Of Association Constitution of Company.pptseri bangash
www.seribangash.com
A Memorandum of Association (MOA) is a legal document that outlines the fundamental principles and objectives upon which a company operates. It serves as the company's charter or constitution and defines the scope of its activities. Here's a detailed note on the MOA:
Contents of Memorandum of Association:
Name Clause: This clause states the name of the company, which should end with words like "Limited" or "Ltd." for a public limited company and "Private Limited" or "Pvt. Ltd." for a private limited company.
https://seribangash.com/article-of-association-is-legal-doc-of-company/
Registered Office Clause: It specifies the location where the company's registered office is situated. This office is where all official communications and notices are sent.
Objective Clause: This clause delineates the main objectives for which the company is formed. It's important to define these objectives clearly, as the company cannot undertake activities beyond those mentioned in this clause.
www.seribangash.com
Liability Clause: It outlines the extent of liability of the company's members. In the case of companies limited by shares, the liability of members is limited to the amount unpaid on their shares. For companies limited by guarantee, members' liability is limited to the amount they undertake to contribute if the company is wound up.
https://seribangash.com/promotors-is-person-conceived-formation-company/
Capital Clause: This clause specifies the authorized capital of the company, i.e., the maximum amount of share capital the company is authorized to issue. It also mentions the division of this capital into shares and their respective nominal value.
Association Clause: It simply states that the subscribers wish to form a company and agree to become members of it, in accordance with the terms of the MOA.
Importance of Memorandum of Association:
Legal Requirement: The MOA is a legal requirement for the formation of a company. It must be filed with the Registrar of Companies during the incorporation process.
Constitutional Document: It serves as the company's constitutional document, defining its scope, powers, and limitations.
Protection of Members: It protects the interests of the company's members by clearly defining the objectives and limiting their liability.
External Communication: It provides clarity to external parties, such as investors, creditors, and regulatory authorities, regarding the company's objectives and powers.
https://seribangash.com/difference-public-and-private-company-law/
Binding Authority: The company and its members are bound by the provisions of the MOA. Any action taken beyond its scope may be considered ultra vires (beyond the powers) of the company and therefore void.
Amendment of MOA:
While the MOA lays down the company's fundamental principles, it is not entirely immutable. It can be amended, but only under specific circumstances and in compliance with legal procedures. Amendments typically require shareholder
RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...BBPMedia1
Marvin neemt je in deze presentatie mee in de voordelen van non-endemic advertising op retail media netwerken. Hij brengt ook de uitdagingen in beeld die de markt op dit moment heeft op het gebied van retail media voor niet-leveranciers.
Retail media wordt gezien als het nieuwe advertising-medium en ook mediabureaus richten massaal retail media-afdelingen op. Merken die niet in de betreffende winkel liggen staan ook nog niet in de rij om op de retail media netwerken te adverteren. Marvin belicht de uitdagingen die er zijn om echt aansluiting te vinden op die markt van non-endemic advertising.
Accpac to QuickBooks Conversion Navigating the Transition with Online Account...PaulBryant58
This article provides a comprehensive guide on how to
effectively manage the convert Accpac to QuickBooks , with a particular focus on utilizing online accounting services to streamline the process.
Putting the SPARK into Virtual Training.pptxCynthia Clay
This 60-minute webinar, sponsored by Adobe, was delivered for the Training Mag Network. It explored the five elements of SPARK: Storytelling, Purpose, Action, Relationships, and Kudos. Knowing how to tell a well-structured story is key to building long-term memory. Stating a clear purpose that doesn't take away from the discovery learning process is critical. Ensuring that people move from theory to practical application is imperative. Creating strong social learning is the key to commitment and engagement. Validating and affirming participants' comments is the way to create a positive learning environment.
The world of search engine optimization (SEO) is buzzing with discussions after Google confirmed that around 2,500 leaked internal documents related to its Search feature are indeed authentic. The revelation has sparked significant concerns within the SEO community. The leaked documents were initially reported by SEO experts Rand Fishkin and Mike King, igniting widespread analysis and discourse. For More Info:- https://news.arihantwebtech.com/search-disrupted-googles-leaked-documents-rock-the-seo-world/
Premium MEAN Stack Development Solutions for Modern BusinessesSynapseIndia
Stay ahead of the curve with our premium MEAN Stack Development Solutions. Our expert developers utilize MongoDB, Express.js, AngularJS, and Node.js to create modern and responsive web applications. Trust us for cutting-edge solutions that drive your business growth and success.
Know more: https://www.synapseindia.com/technology/mean-stack-development-company.html
Personal Brand Statement:
As an Army veteran dedicated to lifelong learning, I bring a disciplined, strategic mindset to my pursuits. I am constantly expanding my knowledge to innovate and lead effectively. My journey is driven by a commitment to excellence, and to make a meaningful impact in the world.
3.0 Project 2_ Developing My Brand Identity Kit.pptxtanyjahb
A personal brand exploration presentation summarizes an individual's unique qualities and goals, covering strengths, values, passions, and target audience. It helps individuals understand what makes them stand out, their desired image, and how they aim to achieve it.
As a business owner in Delaware, staying on top of your tax obligations is paramount, especially with the annual deadline for Delaware Franchise Tax looming on March 1. One such obligation is the annual Delaware Franchise Tax, which serves as a crucial requirement for maintaining your company’s legal standing within the state. While the prospect of handling tax matters may seem daunting, rest assured that the process can be straightforward with the right guidance. In this comprehensive guide, we’ll walk you through the steps of filing your Delaware Franchise Tax and provide insights to help you navigate the process effectively.
India Orthopedic Devices Market: Unlocking Growth Secrets, Trends and Develop...Kumar Satyam
According to TechSci Research report, “India Orthopedic Devices Market -Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030”, the India Orthopedic Devices Market stood at USD 1,280.54 Million in 2024 and is anticipated to grow with a CAGR of 7.84% in the forecast period, 2026-2030F. The India Orthopedic Devices Market is being driven by several factors. The most prominent ones include an increase in the elderly population, who are more prone to orthopedic conditions such as osteoporosis and arthritis. Moreover, the rise in sports injuries and road accidents are also contributing to the demand for orthopedic devices. Advances in technology and the introduction of innovative implants and prosthetics have further propelled the market growth. Additionally, government initiatives aimed at improving healthcare infrastructure and the increasing prevalence of lifestyle diseases have led to an upward trend in orthopedic surgeries, thereby fueling the market demand for these devices.
5. Alcon American pharmaceutical firm Founded in 1945 by R.Alexander & W.Coner 2008 turnover: $ 6 293 billion Employees: 15 000
6. Reasons of the takeover 28 billion dollars Strengthen innovation power & diversify its range of medication Together they cover more than 70% of the global vision care sector Benefice for the shareholders, employees and patients
7. Stock Market - Alcon 19th February stock price : $ 159.08 15th March stock price: $162.48